Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kwang-Hyub Han

Showing results (1-10 of 548) with videos related to

Pageof 55
Sort By:
Gastroenterology & Hepatology|December 13, 2018
Treatment of Hepatocellular Carcinoma With LenvatinibKwang-Hyub Han
Journal of Gastroenterology and Hepatology|July 3, 2010
Systemic treatment in advanced/metastatic hepatocellular carcinoma in the era of targeted therapyKwang-Hyub Han, Jun Yong Park
Hepatology International|April 30, 2016
Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modalityDo Young Kim, Kwang-Hyub Han
Intervirology|March 24, 2005
How to predict HCC development in patients with chronic B viral liver disease?Kwang-Hyub Han, Sang Hoon Ahn
Hepatic Oncology|September 8, 2018
Impact of a shortened surveillance interval on hepatocellular carcinoma survivalDo Young Kim, Kwang-Hyub Han
Liver Cancer|October 26, 2013
Epidemiology and surveillance of hepatocellular carcinomaDo Young Kim, Kwang-Hyub Han
Journal of Gastroenterology and Hepatology|October 21, 2011
Sorafenib, doesn't it have any competitor in advanced hepatocellular carcinoma?Do Young Kim, Kwang-Hyub Han
The Korean Journal of Hepatology|June 26, 2004
[Peginterferon-alpha and ribavirin combination therapy in chronic hepatitis C]Kwang-Hyub Han, Young Hoon Yoon
Oncology|July 10, 2010
Positioning and indication of sorafenib in the treatment algorithm and real practice setting: Western and eastern approach--Asian perspectiveJung Min Lee, Kwang-Hyub Han
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 20, 2007
Liver cancer in KoreaKwang-Hyub Han, Ja Kyung Kim
Pageof 55

Showing results (1-10 of 548) with videos related to

Sort By:
Pageof 55
Gastroenterology & Hepatology|December 13, 2018
Treatment of Hepatocellular Carcinoma With LenvatinibKwang-Hyub Han
Journal of Gastroenterology and Hepatology|July 3, 2010
Systemic treatment in advanced/metastatic hepatocellular carcinoma in the era of targeted therapyKwang-Hyub Han, Jun Yong Park
Hepatology International|April 30, 2016
Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modalityDo Young Kim, Kwang-Hyub Han
Intervirology|March 24, 2005
How to predict HCC development in patients with chronic B viral liver disease?Kwang-Hyub Han, Sang Hoon Ahn
Hepatic Oncology|September 8, 2018
Impact of a shortened surveillance interval on hepatocellular carcinoma survivalDo Young Kim, Kwang-Hyub Han
Liver Cancer|October 26, 2013
Epidemiology and surveillance of hepatocellular carcinomaDo Young Kim, Kwang-Hyub Han
Journal of Gastroenterology and Hepatology|October 21, 2011
Sorafenib, doesn't it have any competitor in advanced hepatocellular carcinoma?Do Young Kim, Kwang-Hyub Han
The Korean Journal of Hepatology|June 26, 2004
[Peginterferon-alpha and ribavirin combination therapy in chronic hepatitis C]Kwang-Hyub Han, Young Hoon Yoon
Oncology|July 10, 2010
Positioning and indication of sorafenib in the treatment algorithm and real practice setting: Western and eastern approach--Asian perspectiveJung Min Lee, Kwang-Hyub Han
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 20, 2007
Liver cancer in KoreaKwang-Hyub Han, Ja Kyung Kim
Pageof 55